🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emily Carbone

ORCID: 0000-0002-6377-2847
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064
Top 100%
0DataRank
Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Papers

Driven by 6 papers — median percentile 0. Top paper: “Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide”.

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3471
N/A
0.546DataRank · unranked
37 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17039
N/A
0.241DataRank · unranked
4 citations

Luisa Fernandez, Kate Cunningham, Natalie Elphick, Ethan Barnett, Jerry S. H. Lee +11 more

Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-1216
N/A
0DataRank · unranked
42 citations

Jimmy L. Zhao, Adam Jendrisak, Emily Carbone, Ethan Barnett, Melanie Hullings +11 more

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064
Top 100%
0DataRank
Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5026
N/A
0DataRank · unranked
0 citations

Andrea Arfè, Ethan Barnett, Erica Simone Dayan, Jimmy L. Zhao, Emily Carbone +5 more

Data from Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

(2023)10.1158/1078-0432.c.6530474.v1
N/A
0DataRank · unranked
0 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more